Fluzone Quadrivalent 2025-2026 vaccine 0.5 mL Prefilled Syringe
RxNorm 2719475 NDC Crossover

NDC Directory Crossover & Product Mapping

The following National Drug Codes (NDCs) are directly associated with the clinical concept for Fluzone Quadrivalent 2025-2026 vaccine 0.5 mL Prefilled Syringe (RxCUI 2719475). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.

Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.

Manufacturer Quick Index

→ Sanofi Pasteur Inc. 2

Sanofi Pasteur Inc.

NDC Product
Vaccine

Fluzone Quadrivalent Northern Hemisphere
NDC 49281-541

Generic Name
Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated)
Dosage Form
Injection, Suspension
Route
Intramuscular
Marketing
BLA
Active Listing
NDC Product
Vaccine

Fluzone Quadrivalent Northern Hemisphere
NDC 49281-926

Generic Name
Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated)
Dosage Form
Injection, Suspension
Route
Intramuscular
Marketing
BLA
Active Listing